Research Solutions Inc. (RSSS) - What Are Brokerages Thinking About This Stock?

Key Points

• Analyst sentiment is mixed: Research Solutions has a consensus “Hold” rating from five analysts, with three buys, one hold, and one sell. The average 12-month price target is $3.83, while Weiss Ratings recently downgraded the stock to “Sell.”
• The stock remains near its 12-month low: RSSS opened at $1.96, compared with a 12-month range of $1.90 to $3.54, and is trading below its 50-day and 200-day moving averages.
• Quarterly results were mixed: Research Solutions reported $12.08 million in revenue, slightly above estimates, but earnings of $0.02 per share missed the $0.04 consensus forecast. Institutional investors own 33.6% of the company.

Research Solutions Inc. (NASDAQ:RSSS - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $3.83.

Separately, Weiss Ratings downgraded shares of Research Solutions from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, October 9th.

Institutional Trading of Research Solutions

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Punch & Associates Investment Management Inc. bought a new position in shares of Research Solutions during the 2nd quarter worth about $5,922,000. Bard Associates Inc. bought a new stake in shares of Research Solutions in the second quarter valued at about $1,413,000. North Star Investment Management Corp. bought a new stake in shares of Research Solutions in the first quarter valued at about $754,000. Navalign LLC lifted its stake in shares of Research Solutions by 154.7% in the first quarter. Navalign LLC now owns 251,126 shares of the company's stock valued at $568,000 after buying an additional 152,546 shares during the period. Finally, BlackRock Inc. acquired a new stake in Research Solutions during the second quarter worth about $332,000. 33.60% of the stock is currently owned by institutional investors and hedge funds.

Research Solutions Stock Down 0.3%

RSSS opened at $1.96 on Thursday. The stock's 50 day moving average price is $2.14 and its two-hundred day moving average price is $2.26. The firm has a market capitalization of $66.17 million, a P/E ratio of 21.78 and a beta of 0.77. Research Solutions has a 12-month low of $1.90 and a 12-month high of $3.54.

Research Solutions (NASDAQ:RSSS - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.02). Research Solutions had a return on equity of 15.55% and a net margin of 5.84%. The business had revenue of $12.08 million for the quarter, compared to analyst estimates of $11.95 million. As a group, analysts anticipate that Research Solutions will post 0.10 earnings per share for the current year.

About Research Solutions

Research Solutions, Inc is a technology company that provides digital tools and marketplaces for the life sciences research industry. Its platforms are designed to help scientists discover, evaluate and procure research products, services and external laboratory capabilities.

The company's offerings include Scientist.com, a research marketplace that connects pharmaceutical, biotechnology, academic and government organizations with suppliers and contract research providers. The platform supports the sourcing and management of outsourced research activities, including laboratory services, testing and other specialized scientific capabilities.

Research Solutions also operates Bioz, a search and discovery platform that helps researchers identify scientific products and assess their use in published research.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.